Profilo
Ian Russell has worked as a Managing Director & Director at Bioscientifica Ltd.
since 2015.
Posizioni attive di Ian Russell
Società | Posizione | Inizio |
---|---|---|
Bioscientifica Ltd.
Bioscientifica Ltd. Commercial Printing/FormsCommercial Services Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015. | Amministratore Delegato | 01/01/2015 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Bioscientifica Ltd.
Bioscientifica Ltd. Commercial Printing/FormsCommercial Services Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015. | Commercial Services |
- Borsa valori
- Insiders
- Ian Russell